Log In
Print
BCIQ
Print
Print this Print this
 

Desmoteplase (DPSA)

  Manage Alerts
Collapse Summary General Information
Company H. Lundbeck A/S
DescriptionGenetically engineered salivary plasminogen activator from the vampire bat Desmodus rotundus
Molecular Target Plasminogen
Mechanism of Action 
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPhase III
Standard IndicationStroke
Indication DetailsTreat acute ischemic stroke; Treat hemorrhagic stroke; Treat stroke
Regulatory Designation

Partner

Bayer AG


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today